» Articles » PMID: 8662635

Domain Structure of the Vaccinia Virus MRNA Capping Enzyme. Expression in Escherichia Coli of a Subdomain Possessing the RNA 5'-triphosphatase and Guanylyltransferase Activities and a Kinetic Comparison to the Full-size Enzyme

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 May 17
PMID 8662635
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The RNA 5'-triphosphatase, nucleoside triphosphate phosphohydrolase, and guanylyltransferase activities of the vaccinia virus mRNA capping enzyme were previously localized to an NH2-terminal 60-kDa domain of the D1R subunit. Measurement of the relative ATPase and guanylyltransferase activities remaining in D1R carboxyl-terminal deletion variants expressed in Escherichia coli BL21(DE3)plysS localizes the carboxyl terminus of the active domain to between amino acids 520 and 545. Failure to obtain a deletion mutant with the loss of one activity indicates that the catalysis of both reactions requires a common domain structure. Based on these results, a truncated D1R protein terminating at amino acid 545 was expressed in E. coli and purified to homogeneity. D1R1-545 was found to be kinetically equivalent to the holoenzyme in regard to ATPase, RNA 5'-triphosphatase, and guanylyltransferase activities. Measurement of RNA binding by mobility shift and UV photo-cross-linking analyses also demonstrates the ability of this domain to bind RNA independent of the methyltransferase domain, comprised of the carboxyl terminus of D1R from amino acids 498-844 and the entire D12L subunit. RNA binding to D1R1-545 is substantially weaker than binding to either the methyltransferase domain or the holoenzyme. Binding is inhibited by 5'-OH RNA and to a lesser extent by DNA oligonucleotides in a concentration dependent manner which correlates with the inhibition of RNA 5'-triphosphatase activity by these same oligonucleotides. We conclude that D1R1-545 represents a functionally independent domain of the mRNA capping enzyme, fully competent in substrate binding and catalysis at both the triphosphatase and guanylyltransferase active sites.

Citing Articles

Characterization, Directed Evolution, and Targeting of DNA Virus-Encoded RNA Capping Enzymes Using Phenotypic Yeast Platforms.

Ornelas M, Thomas A, Johnson Rosas L, Medina G, Mehta A ACS Chem Biol. 2023; 18(8):1808-1820.

PMID: 37498174 PMC: 11024868. DOI: 10.1021/acschembio.3c00243.


Synthetic mRNA capping.

Muttach F, Muthmann N, Rentmeister A Beilstein J Org Chem. 2018; 13:2819-2832.

PMID: 30018667 PMC: 5753152. DOI: 10.3762/bjoc.13.274.


A general method for rapid and cost-efficient large-scale production of 5' capped RNA.

Fuchs A, Neu A, Sprangers R RNA. 2016; 22(9):1454-66.

PMID: 27368341 PMC: 4986899. DOI: 10.1261/rna.056614.116.


Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant.

Tate J, Boldt R, McFadden B, DCosta S, Lewandowski N, Shatzer A Virology. 2015; 487:27-40.

PMID: 26496697 PMC: 4679637. DOI: 10.1016/j.virol.2015.10.011.


RNA methyltransferases involved in 5' cap biosynthesis.

Byszewska M, Smietanski M, Purta E, Bujnicki J RNA Biol. 2015; 11(12):1597-607.

PMID: 25626080 PMC: 4615557. DOI: 10.1080/15476286.2015.1004955.